Driehaus Capital Management
North America, Illinois, United States, Chicago
Description
Driehaus is an investment management firm that manages growth equity investment strategies and multi-asset alternative strategies.
Investor Profile
Driehaus Capital Management has backed more than 44 startups, with 8 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 26 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Switzerland.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Post Ipo Equity (43%)
- Series B (23%)
- Series C (14%)
- Series A (7%)
- Series Unknown (5%)
- Series E (2%)
- Series G (2%)
- Seed (2%)
- Undisclosed (2%)
Country Focus
- United States (89%)
- United Kingdom (2%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Switzerland (2%)
- Belgium (2%)
- Canada (2%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Biopharma
- Health Diagnostics
- Life Science
- Oncology
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
